Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01885455 · ClinicalTrials.gov registry record · NA

Improving Resection Rates Among African Americans With NSCLC

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
248
Enrollment target

NCT01885455 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 248 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01885455, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target

Study Summary

This is a randomized, interventional trial in which the navigation is the intervention. Phase is not applicable. The study is a randomized trial to evaluate the impact of a nurse-led patient navigation intervention in improving rates of receipt of lung-directed therapy with curative intent (LDTCI) among African Americans with early stage lung cancer. Study sites are cluster-randomized to either the usual care study arm or the to the navigation intervention study arm. Randomization occurred at the level of the study site rather than at the level of individual participants. There are two arms.

Interventions

  • OTHER Usual Care
  • OTHER Intervention Arm

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2015-04-23
Est. Completion 2019-09-09
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT01885455

The ClinicalTrials.gov registry entry for NCT01885455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT01885455 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01885455 about?

NCT01885455 is a clinical study titled "Improving Resection Rates Among African Americans With NSCLC". This is a randomized, interventional trial in which the navigation is the intervention. Phase is not applicable. The study is a randomized trial to evaluate the impact of a nurse-led patient navigation intervention in improving rates of receipt of lung-directed therapy with curative intent (LDTCI) a...

What is the current status of trial NCT01885455?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2015-04-23. Estimated completion is 2019-09-09.

What interventions are being tested in trial NCT01885455?

The interventions under investigation include: Usual Care (OTHER), Intervention Arm (OTHER).

Who is sponsoring clinical trial NCT01885455?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.